Marksans Pharma’s wholly owned subsidiary -- Relonchem in UK has received marketing authorization for its Mefenamic Acid 250 mg Film-Coated Tablets and Mefenamic Acid 500 mg Film-Coated Tablets from UK Medicines & Healthcare products Regulatory Agency (UK MHRA).
Marksans Pharma is engaged in Research, Manufacturing & Marketing of generic pharmaceutical formulation in the global markets.